sb 216763 has been researched along with Acute Radiation Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daniel, AR; Kirsch, DG; Lee, CL; Luo, L; Ma, Y; Oh, P | 1 |
| Castle, KD; Chao, NJ; Kirsch, DG; Lee, CL; Lento, WE | 1 |
2 other study(ies) available for sb 216763 and Acute Radiation Syndrome
| Article | Year |
|---|---|
Inhibiting Glycogen Synthase Kinase-3 Mitigates the Hematopoietic Acute Radiation Syndrome in a Sex- and Strain-dependent Manner in Mice.
Topics: Acute Radiation Syndrome; Animals; Bone Marrow; Female; Glycogen Synthase Kinase 3; Hematopoiesis; Indoles; Male; Maleimides; Mice; Mice, Inbred C57BL; Mice, Transgenic; Protein Kinase Inhibitors; Radiation-Protective Agents; Sex Factors; Species Specificity | 2020 |
Inhibiting glycogen synthase kinase-3 mitigates the hematopoietic acute radiation syndrome in mice.
Topics: Acute Radiation Syndrome; Aminophenols; Animals; Apoptosis; Bone Marrow; Cells, Cultured; Colony-Forming Units Assay; Drug Evaluation, Preclinical; Glycogen Synthase Kinase 3; Hematopoiesis; Hematopoietic Stem Cells; Indoles; Injections, Subcutaneous; Maleimides; Mice; Mice, Inbred C57BL; Oximes; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Radiation Injuries, Experimental; Whole-Body Irradiation | 2014 |